158 related articles for article (PubMed ID: 1394666)
1. Synthesis and antitumor activity of fused quinoline derivatives. III. Novel N-glycosylamino-indolo[3,2-b]quinolines.
Takeuchi Y; Chang MR; Hashigaki K; Tashiro T; Tsuruo T; Tsukagoshi S; Yamato M
Chem Pharm Bull (Tokyo); 1992 Jun; 40(6):1481-5. PubMed ID: 1394666
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antitumor activity of 7-(N-glycosylamino)-indolo[3,2-b]quinolines.
Takeuchi Y; Chang MR; Hashigaki K; Yamato M
Chem Pharm Bull (Tokyo); 1991 Jun; 39(6):1629-31. PubMed ID: 1934189
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antitumor activity of fused quinoline derivatives. V. Methylindolo[3,2-b]quinolines.
Takeuchi Y; Kitaomo M; Chang MR; Shirasaka S; Shimamura C; Okuno Y; Yamato M; Harayama T
Chem Pharm Bull (Tokyo); 1997 Dec; 45(12):2096-9. PubMed ID: 9433781
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antitumor activity of fused quinoline derivatives. II. Novel 4- and 7-hydroxyindolo-[3,2-b]quinolines.
Yamato M; Takeuchi Y; Chang MR; Hashigaki K
Chem Pharm Bull (Tokyo); 1992 Feb; 40(2):528-30. PubMed ID: 1606653
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antitumor activity of fused quinoline derivatives. IV. Novel 11-aminoindolo[3,2-b]quinolines.
Takeuchi Y; Oda T; Chang MR; Okamoto Y; Ono J; Oda Y; Harada K; Hashigaki K; Yamato M
Chem Pharm Bull (Tokyo); 1997 Feb; 45(2):406-11. PubMed ID: 9118455
[TBL] [Abstract][Full Text] [Related]
6. Heterocyclic quinones. XIV. Pharmacomodulation in a series of 11H-indolo[3,2-c]quinolinediones: synthesis and cytotoxicity of 8-substituted 11H-indolo[3,2-c]quinoline-7,10-diones.
Helissey P; Giorgi-Renault S; Renault J; Cros S
Chem Pharm Bull (Tokyo); 1989 Mar; 37(3):675-9. PubMed ID: 2752476
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro antiproliferative activity of new 11-aminoalkylamino-substituted 5H- and 6H-indolo[2,3-b]quinolines; structure-activity relationships of neocryptolepines and 6-methyl congeners.
Wang L; Switalska M; Mei ZW; Lu WJ; Takahara Y; Feng XW; El-Sayed Iel-T; Wietrzyk J; Inokuchi T
Bioorg Med Chem; 2012 Aug; 20(15):4820-9. PubMed ID: 22748378
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationship of methyl-substituted indolo[2,3-b]quinolines: novel cytotoxic, DNA topoisomerase II inhibitors.
Peczyńska-Czoch W; Pognan F; Kaczmarek L; Boratyński J
J Med Chem; 1994 Oct; 37(21):3503-10. PubMed ID: 7932579
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, antitumor evaluation and SAR of new 1H-pyrrolo [3,2-c] quinoline-6,9-diones and 11H-indolo [3,2-c] quinoline-1,4-diones.
Helissey P; Cros S; Giorgi-Renault S
Anticancer Drug Des; 1994 Feb; 9(1):51-67. PubMed ID: 8141966
[TBL] [Abstract][Full Text] [Related]
10. A convenient synthesis of 1H-pyrrolo[3,2-c]quinoline-6,9-diones and 11H-indolo[3,2-c]quinoline-1,4-diones derivatives.
Helissey P; Parrot-Lopez H; Renault J; Cros S
Chem Pharm Bull (Tokyo); 1987 Sep; 35(9):3547-57. PubMed ID: 3435963
[No Abstract] [Full Text] [Related]
11. Design of antineoplastic agents based on the '2-phenylnaphthalene-type' structural pattern--synthesis and biological activity studies of 11H-indolo[3.2-c]quinoline derivatives.
He L; Chang HX; Chou TC; Savaraj N; Cheng CC
Eur J Med Chem; 2003 Jan; 38(1):101-7. PubMed ID: 12593920
[TBL] [Abstract][Full Text] [Related]
12. [Synthesis of potential antitumor agents: nitrogen mustards based on quinoline].
Pellerano C; Savini L
Farmaco Sci; 1984 Aug; 39(8):681-5. PubMed ID: 6479326
[TBL] [Abstract][Full Text] [Related]
13. Heterocyclic quinones. XVI. Pharmacomodulation in the series of 11H-indolo[3,2-c]quinolinediones: synthesis, cytotoxicity and antitumor activity of 3-substituted 11H-pyrido[3',4':4,5]pyrrolo[3,2-c]quinoline-1,4-diones.
Helissey P; Giorgi-Renault S; Renault J; Cros S
Chem Pharm Bull (Tokyo); 1989 Sep; 37(9):2413-6. PubMed ID: 2557983
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antitumor activity of fused quinoline derivatives.
Yamato M; Takeuchi Y; Chang MR; Hashigaki K; Tsuruo T; Tashiro T; Tsukagoshi S
Chem Pharm Bull (Tokyo); 1990 Nov; 38(11):3048-52. PubMed ID: 2085886
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound-assisted Synthesis of 6-substituted indolo[2,3-b]quinolines: their Evaluation as Potential Cytotoxic Agents.
Marepu N; Gosi M; Vedula SS; Yeturu S; Pal M
Mini Rev Med Chem; 2019; 19(7):599-608. PubMed ID: 30058486
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, and cytotoxic activity of some novel indolo[2,3-b]quinoline derivatives: DNA topoisomerase II inhibitors.
Kaczmarek L; Peczyńska-Czoch W; Osiadacz J; Mordarski M; Sokalski WA; Boratyński J; Marcinkowska E; Glazman-Kuśnierczyk H; Radzikowski C
Bioorg Med Chem; 1999 Nov; 7(11):2457-64. PubMed ID: 10632055
[TBL] [Abstract][Full Text] [Related]
17. [Synthesis and biological activity of new compounds with the 1,3-dioxol(4,5-g)quinoline structure].
Pellerano C; Savini L
Farmaco Sci; 1984 Jul; 39(7):640-8. PubMed ID: 6479323
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of 4-quinolylazide derivatives and evaluation of their antitumor and antimicrobial activity.
Savini L; Massarelli P; Pellerano C
Farmaco; 1993 Apr; 48(4):515-28. PubMed ID: 8357467
[TBL] [Abstract][Full Text] [Related]
19. New derivatives of 11-methyl-6-[2-(dimethylamino)ethyl]-6H-indolo[2,3-b]quinoline as cytotoxic DNA topoisomerase II inhibitors.
Luniewski W; Wietrzyk J; Godlewska J; Switalska M; Piskozub M; Peczynska-Czoch W; Kaczmarek L
Bioorg Med Chem Lett; 2012 Oct; 22(19):6103-7. PubMed ID: 22944121
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antitumor evaluation of novel monoindolyl-4-trifluoromethylpyridines and bisindolyl-4-trifluoromethylpyridines.
Jiang B; Xiong XN; Yang CG
Bioorg Med Chem Lett; 2001 Feb; 11(4):475-7. PubMed ID: 11229751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
